Loading clinical trials...
Loading clinical trials...
Coenzyme Q10 (CoQ10) is an essential molecule in human body. It acts as an antioxidant, a co-factor for energy conversion in mitochondria and has anti-inflammatory effects capable of improving endothelial function. Our goal is to investigate whether CoQ10 is capable to reduce the incidence of acute kidney injury/failure following cardiac surgery. Cardiac surgery is major risk factor for acute kidney injury/failure (AKI/F).
Age
40 - No limit years
Sex
ALL
Healthy Volunteers
No
Clinical Hospital Center Split
Split, Split-Dalmatia County, Croatia
Start Date
July 15, 2020
Primary Completion Date
September 1, 2021
Completion Date
December 1, 2021
Last Updated
July 16, 2020
100
ESTIMATED participants
Coenzyme Q10
DIETARY_SUPPLEMENT
Lead Sponsor
Clinical Hospital Center, Split
NCT05806645
NCT07472426
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07447791